Navigation Links
AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
Date:2/11/2008

WEST CHESTER, Ohio, Feb. 11 /PRNewswire-FirstCall/ -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation products, today announced that the first patient was successfully treated in AtriCure's ABLATE clinical trial. Dr. Richard Kaplon, a well-known cardiac surgeon, performed the procedure at Mercy General Hospital in Sacramento, California.

The purpose of the ABLATE clinical trial is to evaluate the safety and effectiveness of AtriCure's Isolator Synergy(TM) bipolar ablation system for reestablishing normal heart rhythm in patients with permanent atrial fibrillation, or AF, requiring concomitant open-heart surgery utilizing the Cox Maze IV procedure. The Isolator Synergy(TM) bipolar ablation system is designed to create precise lesions, or scars, on heart muscle, which block irregular electrical signals and restore normal sinus rhythm.

This prospective, non-randomized clinical trial is expected to enroll approximately 70 patients at 10 medical centers in the United States. The primary efficacy endpoints for the trial are patients being free from AF and off anti-arrhythmic drugs at six months. Upon the completion of a successful trial, the results will be submitted to the FDA as part of a Pre-Market Approval, or PMA, in support of an AF indication for our Isolator Synergy(TM) bipolar ablation system when used to treat patients undergoing concomitant open-heart surgery.

Dr. Richard Kaplon commented, "Patients who have AF are at significant risk for stroke and death when compared to patients in normal sinus rhythm. We believe that this is an important treatment for our patients. Based on our group's experience using the Isolator Synergy(TM) bipolar ablation system, we believ
'/>"/>

SOURCE AtriCure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
2. Genta Announces Common Stock Offering of Approximately $3.1 Million
3. Chakshu Research Announces Appointment of Dr. Randall Olson as Director
4. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
5. Exelixis Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
6. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
7. Kosan Announces February 28, 2008 Conference Call and Webcast
8. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
9. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
10. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service
11. Bioponic Phytoceuticals Announces Record Sales Increase of 40% for the Month of January
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... PARK, Calif. , Feb. 26, 2015 ... released the latest version of the Governance Portal ... accomplish governance, risk and compliance (GRC) tasks across multiple ... also been updated to help customers better align their ... of the Treadway Commission ) requirements. In response to ...
(Date:2/26/2015)... On behalf of biotech client GenScript USA, ... & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript’s ... for judgment notwithstanding the verdict, a new trial, and ...
(Date:2/26/2015)... -- BioEnterprise today announced that Northeast Ohio ... billion in growth funding during the past 13 years.  ... state – including the Ohio Third Frontier - and ... been raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... Innovation is more urgent than ever. Radical business ... world and transforming global markets in industry after ... care, disruption is constantly underway. , As technology ... the foundations of established business models, large-scale innovation ... the next wave of mega-change. , This wave ...
Breaking Biology Technology:Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2
... NOVEMBER 4, 2008, SAN DIEGO, Oct. 27 ... Kevin Gorman, President and Chief,Executive Officer of Neurocrine Biosciences ... in New York., The live presentation takes place ... /7:00 a.m. Pacific Time (PT). The presentation will,be simultaneously ...
... at 4:30 p.m. ET -, SOUTH SAN FRANCISCO, ... ) today reported financial results for the,quarter ended September ... million for the third quarter of,2008, 55% higher than ... was driven by revenue from Trofile(TM) for selecting HIV ...
... Lead Epidemiologist, RALEIGH, N.C., Oct. 27 ... the appointment of Dr.,Jerome Wilson as Senior Medical ... Dr. Wilson is responsible for providing consulting,services and ... provides extensive Phase IV Post-Marketing services to,pharmaceutical and ...
Cached Biology Technology:Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference 2Monogram Announces 2008 Third Quarter Financial Results 2Monogram Announces 2008 Third Quarter Financial Results 3Monogram Announces 2008 Third Quarter Financial Results 4Monogram Announces 2008 Third Quarter Financial Results 5Monogram Announces 2008 Third Quarter Financial Results 6Monogram Announces 2008 Third Quarter Financial Results 7Monogram Announces 2008 Third Quarter Financial Results 8Monogram Announces 2008 Third Quarter Financial Results 9Monogram Announces 2008 Third Quarter Financial Results 10Monogram Announces 2008 Third Quarter Financial Results 11Monogram Announces 2008 Third Quarter Financial Results 12Monogram Announces 2008 Third Quarter Financial Results 13Monogram Announces 2008 Third Quarter Financial Results 14Monogram Announces 2008 Third Quarter Financial Results 15Jerome Wilson Joins PRA International's Late Phase Service Group 2
(Date:2/24/2015)... 24, 2015 Research and Markets ... the "Global 2D Gesture Recognition Market 2015-2019" ... The analysts forecast the Global 2D Gesture Recognition ... over the period 2014-2019 The increased ... is one of the major trends in the ...
(Date:2/19/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ) ... Electro-Optical / Infrared Systems Market by Type, by ... to 2020" report to their offering. ... expected to reach $16.35 billion by 2020, to ... report segments the military electro-optical/infrared systems market on ...
(Date:2/13/2015)... Feb. 13, 2015 ACT Genomics Co., ... aims to transform cancer genomic information into precision ... company has raised US$ 8 million in the its ... Taipei, Taiwan , ACT Genomics ... With the aim to implement next generation sequencing ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... A protein that was first identified for playing a key ... significant in helping muscle cells survive the forces of muscle ... have a form of muscular dystrophy. A group ... in human red blood cells by Vann Bennett, M.D. a ...
... 2008 BBVA Foundation Frontiers of Knowledge Award in the Climate ... to U.S. researcher Wallace S. Broecker, who more than three ... human activity. In 1975, Broecker published the article "Climate Change: ... in the journal Science , marking the first ever ...
... -- The official State Dinosaur of Texas is up for ... proved the titleholder has been misidentified. State Rep. Charles ... change the name of the state dinosaur from Pleurocoelus ... massive sauropod ,whose tracks and bones litter the central Texas ...
Cached Biology News:Cell 'anchors' required to prevent muscular dystrophy 2Cell 'anchors' required to prevent muscular dystrophy 3Wallace S. Broecker wins the BBVA Foundation Frontiers of Knowledge Award in Climate Change 2A case of mistaken dino-identity 2
... The MiniOpticon 2-color real-time PCR detection system holds ... An array of 48 LEDs independently excites fluorescence (470-500 ... photodiodes detects emitted light (523-543 nm and 540-700 nm). ... the MJ Mini thermal cycler. System dimensions are 18 ...
... FC 500 Series is a ... the most advanced technologies available. ... flexible testing, powerful software and ... help researchers optimize their overall ...
... Reader is Cellomics‘ latest product ... Cell-based Screening". The KineticScan Reader ... do both temporal and high-resolution ... dynamic distribution and activity of ...
... be superior to transfection in some applications. ... PULSin you can study lethal proteins and ... proteins in cells. Likewise, delivery of blocking ... RNA interference experiments. ,With PULSin you ...
Biology Products: